XORTX Therapeutics Inc. announced the results of its annual and special meeting of shareholders held on March 24, 2026, where all presented matters were approved, including the election of five directors, appointment of auditors, and approval of a share consolidation.
Key takeaways
Annual and special meeting of shareholders was held on March 24, 2026.
2,407,148 common shares were represented at the meeting, representing approximately 35% of total issued and outstanding shares.
All five management nominees were elected to the board of directors: Anthony Giovinazzo (Chair), Allen Davidoff (CEO), Mika Grasso, Richard Grieve, and George Scorsis.
Davidson & Company LLP was appointed as auditors for the ensuing year.
The stock option plan was re-approved and a share consolidation was approved.